Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- CheckyesterdayChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added to the list of Other Study ID Numbers, signifying NIH funding/identifier associated with the LEAP-005 study.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small patch to the page's tooling. No substantive study content or user-facing information appears to have changed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer’s Revision tag was updated from v3.6.3 to v3.6.4, indicating a small underlying update to the page or its template. This change does not alter the study details or displayed information.SummaryDifference0.0%

- Check51 days agoChange DetectedA final publication citation for LEAP-005 colorectal cancer results was added to the Publications section (Clin Colorectal Cancer. 2026 Jun;25(2):225-238.e2). The previous online-ahead-of-print citation (Clin Colorectal Cancer. 2026 Jan 22:S1533-0028(26)00005-8) was removed/replaced with the finalized record.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects an updated version of the study details page rather than a substantive change to its content.SummaryDifference0.0%

- Check73 days agoChange DetectedEnrollment status updated to show completion and no longer recruiting. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) plus a revision tag (v3.6.0) were added, and the Intervention/Treatment header formatting was standardized.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.